Mulmit

RECURSION PHARMACEUTICALS, INC.RECURSION PHARMACEUTICALS, INC.

RXRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3174,681,000-648,132,000-644,759,000-1.44
2024-12-3158,839,000-479,004,000-463,661,000-1.69
2023-12-3144,575,000-350,060,000-328,066,000-1.58
2022-12-3139,843,000-245,727,000-239,476,000-1.36
2021-12-3110,178,000-182,775,000-186,479,000-1.49

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Borgeson Blake30,000
2026-08-17Khan NajatCEO and President80,498
2026-08-17Hallett DavidChief Scientific Officer26,657
2026-08-17Taylor Ben RChief Financial Officer25,018
2026-08-04Borgeson Blake30,000
2026-07-07Borgeson Blake40,000
2026-07-01Dar Zavain5,109
2026-07-01Li Dean Y3,747
2026-06-18Bumpus Namandje3,963
2026-06-17Borgeson Blake88,424
2026-06-17HERSHBERG ROBERT88,424
2026-06-17Michor Franziska88,424

8-K events

FiledItems
2026-08-05Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-06-18Submission of matters to a vote
2026-05-06Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-04-30Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-03-25Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-02-25Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-01-12Regulation FD disclosure · Financial statements and exhibits
2025-12-08Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.